Patrick H O’ruane

Patrick has developed drug-delivery products in the Surgical, CV, ENT, GI and Transdermal spaces over the past 20 years. He most recently served as CTO at Allay Therapeutics, prior to that he was CTO at Chrono Therapeutics, VP of R&D at CV Ingenuity (acquired by Covidien) and has held various positions in R&D at Xtent, Cook Group and Navigant Biotechnologies.

He received his primary degrees in Chemistry from The Galway-Mayo Institute of Technology and Trinity College Dublin, his Ph.D. from University College Dublin and Post-Doctoral Fellowships at University of Toronto, The Johns Hopkins University and Ohio State University. He is published extensively in both academic and patent literature.